Our study shows a declining rate of recurrence over the decades, suggesting that for a woman treated today, the expected recurrence rate should be lower than that seen in the randomized trials.
Kimberly J. Van Zee, MD, MS
Advertisement
Articles by Kimberly J. Van Zee, MD, MS
Advertisement
Latest Updated Articles
New Data on DCIS Recurrence Good News for Patients Electing Breast-Conserving SurgeryPublished: September 21st 2015 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Novel SSTR-Targeted Alpha Therapy Shows “Encouraging” Activity in GEP-NETs
2
Durvalumab Plus Concurrent CRT Does Not Add Benefit in Stage III NSCLC
3
Matched donor allogeneic CAR T for adult B-ALL: toxicity, efficacy, repeat dosing, and the importance of lymphodepletion
4
Radiotherapy Plus Chemoimmunotherapy Improves Frontline ES-SCLC Prognosis
5
